Dr Shu on Advances in Adjuvant Therapy For Early-Stage NSCLC

Catherine Ann Shu, MD, discusses key therapeutic advances in the adjuvant setting for patients with early-stage non–small cell lung cancer.

Related Keywords

,Catherine Shu ,Columbia University Herbert Irving Comprehensive Cancer Center ,Thoracic Medical Oncology Service ,Price Family Associate Professor ,Nsclc ,Adjuvant Therapy ,Lung ,Osimertinib ,